Q4 2022 · 13F-HR
CHI Advisors LLCholdings as filed
Filed 2023-02-13 · accession 0001085146-23-001058
$375.5M
Reported value
23
Positions
2022-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 74349U108 | — | PROMETHEUS BIOSCIENCES INC | $101.6M | 27.1% | 923,800 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $61.3M | 16.3% | 3,169,892 | Common | SOLE |
| H9060V101 | — | VECTIVBIO HLDG AG | $47.6M | 12.7% | 5,492,893 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $41.2M | 11.0% | 2,800,126 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $35.0M | 9.32% | 3,317,544 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $14.3M | 3.82% | 3,473,366 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $14.2M | 3.79% | 2,829,712 | Common | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $13.3M | 3.54% | 1,889,451 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $10.3M | 2.75% | 215,059 | Common | SOLE |
| 68217N105 | — | OMEGA THERAPEUTICS INC | $6.0M | 1.61% | 1,055,882 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $4.8M | 1.27% | 726,109 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $4.4M | 1.16% | 1,637,372 | Common | SOLE |
| 74019P108 | — | PRECISION BIOSCIENCES INC | $4.2M | 1.13% | 3,549,820 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $3.1M | 0.83% | 333,252 | Common | SOLE |
| 68570P101 | — | ORCHARD THERAPEUTICS PLC | $3.0M | 0.79% | 7,987,396 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $2.3M | 0.62% | 2,204,876 | Common | SOLE |
| 35655L107 | — | FREELINE THERAPEUTICS HLDGS | $2.3M | 0.61% | 4,814,419 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $2.0M | 0.54% | 2,384,402 | Common | SOLE |
| 3621LQ109 | GTHXEUR | G1 THERAPEUTICS INC | $1.8M | 0.48% | 333,945 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $1.6M | 0.43% | 864,822 | Common | SOLE |
| 68236R103 | — | ONCORUS INC | $599,672 | 0.16% | 2,367,436 | Common | SOLE |
| 25460G716 | LABDUSD | DIREXION SHS ETF TR | $431,250 | 0.11% | 25,000 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $29,250 | 0.01% | 30,000 | CALL | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.